Cybin (HELP) Non-cash Items (2020 - 2025)
Cybin's (HELP) quarterly Non-cash Items came in at -$37.8 million in Q4 2025, down 101.67% YoY from $2.3 billion in Q4 2024, and down 37.93% on a QoQ basis from -$27.4 million in Q3 2025.
Cybin (HELP) Non-cash Items (2020 - 2025) Analysis & Trends
Cybin (HELP) has 6 years of Non-cash Items data on file, last reported at -$37.8 million in Q4 2025.
- Quarterly Non-cash Items fell 101.67% year-over-year to -$37.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$109.8 million (down 89.86% YoY) and the FY2021 annual result came in at -$13.4 million, changed N/A from the prior year.
- Non-cash Items retreated to -$37.8 million in Q4 2025, from -$27.4 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of -$5.4 million in Q1 2021 to a low of -$37.8 million in Q4 2025.
- A 5-year average of -$14.3 million and a median of -$9.5 million in 2021 frame the typical range for Non-cash Items.
- Annual changes were most pronounced in 2021 — Non-cash Items slumped 555.47% — and 2022, when it climbed 15.46%.
- Tracing HELP's Non-cash Items over 5 years: stood at -$9.5 million in 2021, then rose by 15.46% to -$8.0 million in 2022, then tumbled by 62.0% to -$13.0 million in 2023, then plunged by 44.58% to -$18.8 million in 2024, then plunged by 101.67% to -$37.8 million in 2025.
- The last three Non-cash Items figures came in at -$37.8 million (Q4 2025), -$27.4 million (Q3 2025), and -$25.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.82 Mn |
| Dec 31, 2025 | -37.82 Mn |
| Sep 30, 2025 | -27.42 Mn |
| Sep 30, 2025 | -27.42 Mn |
| Jun 30, 2025 | -25.77 Mn |
| Jun 30, 2025 | -25.77 Mn |
| Dec 31, 2024 | -18.76 Mn |
| Dec 31, 2024 | -18.76 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Jun 30, 2024 | -10.28 Mn |
| Jun 30, 2024 | -10.28 Mn |
| Dec 31, 2023 | -12.97 Mn |
| Dec 31, 2023 | -12.97 Mn |
| Sep 30, 2023 | -9.24 Mn |
| Sep 30, 2023 | -9.24 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Dec 31, 2022 | -8.01 Mn |
| Dec 31, 2022 | -8.01 Mn |